Impact of CD73 + CD39 + B Cells on Immune Evasion in Pancreatic Cancer
Anticancer Research · 2026
DOI: 10.21873/anticanres.18437 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2026. Verfasst von Mikiya Kishino und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Division of Gastrointestinal and Pediatric Surgery, Faculty of Medicine, Tottori University, Tottori, Japan. Hauptthemen laut MEDLINE: 5'-Nucleotidase, Pancreatic Neoplasms, Apyrase, Antigens, CD.
Abstract (Originalsprache)
BACKGROUND/AIM: Cell surface CD39 and CD73 degrade adenosine triphosphate (ATP) into adenosine, promoting immune tolerance in tumor immunity. In this study, we aimed to characterize regulatory B cells (Bregs) and adenosine-producing B cells in pancreatic cancer (PC) and elucidate the underlying mechanisms of immune evasion. MATERIALS AND METHODS: Ten patients with PC were recruited, then peripheral blood mononuclear cells (PBMCs) were collected pre-neoadjuvant chemotherapy (NAC), post-NAC, and postoperatively. The frequencies of CD73+CD39+ B cells and Bregs were analyzed by flow cytometry. The prognostic significance of CD73 expression in the tumor stroma was evaluated in 106 PC patients through immunohistochemistry (IHC) staining. RESULTS: IHC analysis demonstrated that CD73 was significantly overexpressed in tumor-infiltrating lymphocytes compared with adjacent normal tissues. Furthermore, high CD73 expression was significantly associated with poorer prognosis compared with low CD73 expression. The frequency of CD19+CD73+CD39+ B cells among PBMCs was significantly lower postoperatively compared with pre-NAC and post-NAC. In PC patients, the frequency of CD73+CD39+ B cells correlated with that of IL-10-producing B cells, with a significant decrease in Bregs observed postoperatively. CONCLUSION: Adenosine-producing immune cells in PC tissues were associated with poor prognosis, whereas CD73+CD39+ B cells decreased during treatment in patients with PC. These findings provide preliminary evidence that adenosine-producing B cells may be associated with clinical outcomes in PC, warranting further investigation in larger cohorts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Division of Gastrointestinal and Pediatric Surgery, Faculty of Medicine, Tottori University, Tottori, Japan.
- Department of Surgery, Division of Gastrointestinal and Pediatric Surgery, Faculty of Medicine, Tottori University, Tottori, Japan; ymurakami@tottori-u.ac.jp.
- Department of Pathology, Faculty of Medicine, Tottori University, Tottori, Japan.
Zitieren
APA
Kishino, M., Murakami, Y., Urakami, K., Uehira, K., Yoshida, J., Yagyu, T., Shimizu, S., Morimoto, M., Kono, Y., Shishido, Y., Miyatani, K., Kihara, K., Matsunaga, T., Yamamoto, M., Takano, S., Sakamoto, T., Umekita, Y., Okuyama, H., & Fujiwara, Y. (2026). Impact of CD73 + CD39 + B Cells on Immune Evasion in Pancreatic Cancer. Anticancer Research. https://doi.org/10.21873/anticanres.18437
Vancouver
Kishino M, Murakami Y, Urakami K, Uehira K, Yoshida J, Yagyu T, et al. Impact of CD73 + CD39 + B Cells on Immune Evasion in Pancreatic Cancer. Anticancer Research. 2026. doi:10.21873/anticanres.18437
BibTeX
@article{Kishino2026,
author = {Kishino, Mikiya and Murakami, Yuki and Urakami, Kei and Uehira, Kentaro and Yoshida, Jun and Yagyu, Takuki and Shimizu, Shota and Morimoto, Masaki and Kono, Yusuke and Shishido, Yuji and Miyatani, Kozo and Kihara, Kyoichi and Matsunaga, Tomoyuki and Yamamoto, Manabu and Takano, Syuichi and Sakamoto, Teruhisa and Umekita, Yoshihisa and Okuyama, Hiroomi and Fujiwara, Yoshiyuki},
title = {Impact of CD73 + CD39 + B Cells on Immune Evasion in Pancreatic Cancer},
journal = {Anticancer Research},
year = {2026},
doi = {10.21873/anticanres.18437}
}
EUVIMED